cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pyxis Oncology Inc
1 own
2 watching
Current Price
$0
$-0.05
(-1.62%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
107.67M
52-Week High
52-Week High
6.92
52-Week Low
52-Week Low
1.1
Average Volume
Average Volume
0.16M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization107.67M
icon52-Week High6.92
icon52-Week Low1.1
iconAverage Volume0.16M
iconDividend Yield--
iconP/E Ratio--
What does the Pyxis Oncology Inc do?
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company s antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Pyxis Oncology Inc make?
News & Events about Pyxis Oncology Inc.
PR Newswire
2 months ago
Thinking about buying stock in Pyxis Oncology, Kingsoft Cloud, Dermata Therapeutics, Faraday Future Intelligent Electric, or Exela Technologies? Thinking about buying stock in Pyxis Oncology, Kingsoft Cloud, Dermata Therapeutics, Faraday Future Intelligent Electric, or Exela Technologies? PR...
Globe Newswire
2 months ago
Milestone marks transition of Pyxis Oncology to a clinical-stage company Preliminary data anticipated in early 2024 CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target ...
Globe Newswire
3 months ago
CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, Pamela Connealy...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today reported financial results for its first quarter ended March 31, 2022. The Company ...
Ticker Report
1 year ago
Pyxis Oncology, Inc. (NASDAQ:PYXS Get Rating) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 421,500 shares, a decline of 21.7% from the March 31st total of 538,500 shares. Approximately 2.1% of the shares ...
Frequently Asked Questions
Frequently Asked Questions
What is Pyxis Oncology Inc share price today?
plus_minus_icon
Can Indians buy Pyxis Oncology Inc shares?
plus_minus_icon
How can I buy Pyxis Oncology Inc shares from India?
plus_minus_icon
Can Fractional shares of Pyxis Oncology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pyxis Oncology Inc stocks?
plus_minus_icon
What is today’s traded volume of Pyxis Oncology Inc?
plus_minus_icon
What is today’s market capitalisation of Pyxis Oncology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pyxis Oncology Inc?
plus_minus_icon
What percentage is Pyxis Oncology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pyxis Oncology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.05
(-1.62%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00